Molnupiravir (Lagevrio) is a potent ribonucleoside analog that blocks SARS-CoV-2 replication by acting as a competitive substrate of virally-encoded RNA-dependent RNA polymerase.
Patient monitoring significantly improved for patients seen in the pharmacist-led clinic due to greater efforts to order labs per policy and prescribe an appropriate DOAC dose.
Leaders must fully understand the benefits of diversity and create an environment in which it thrives to cultivate and inspire the next generation of inclusive leaders.
Reducing stigma, improving mental health benefits, and addressing workload concerns all need to happen simultaneously.
New analysis shows the substitution would cut costs by $600 million in the United States annually.
Lisa Nodzon, PhD, ARNP, AOCNP; Katie Tobon, PharmD, BCOP; and Javier Pinilla-Ibarz, MD, PhD, share insight on strategies for the monitoring and management of BTK inhibitor–associated toxicities in CLL and review the importance of a multidisciplinary approach to treatment.
The increasing economic burden of treatment may impact patient outcomes.
The rising use of prescription stimulants in the US presents significant safety risks, legal challenges, and supply chain shortages, emphasizing the need for pharmacist involvement in promoting responsible prescribing.
As job duties continue to change, having coverage protects against alleged errors or omissions.
Bioavailability of dronedarone is markedly increased when administered with food. To maximize absorption, patients should take dronedarone with a complete meal (ideally >500 calories).
In an ambitious effort to address the ongoing uncertainty within the 340B Program space, 6 senators released a draft discussion bill earlier this year titled the SUSTAIN Act.
By understanding the nuances of PBM audit strategies, pharmacies can implement proactive measures to mitigate risks of recoupment, payment suspensions, and, in severe cases, network termination.
Programs can take several forms, including on-site clinics, voucher programs, and in-store events
One of the most important drivers of a patients’ uncontrolled hypertension is medication nonadherence.
The most common cause of death for patients with non-alcoholic fatty liver disease is cardiovascular disease, but it also increases the risk of hepatocellular carcinoma and may surpass hepatitis B and C as the leading cause of this cancer.
An inclusive apprenticeship program aligns with evolving roles, fosters growth, and positively affects patient care.
Well-designed incentives and education can help address COVID-19 vaccine hesitancy and bolster vaccination rates.
Remote work has been a growing trend across many different areas of pharmacy.
Notable contributions from female leaders in the pharmaceutical industry demonstrate the exceptional competence of women in vaccine innovation.
It is imperative for health care professionals, especially pharmacists, to be well-informed regarding the physiological impact of Ramadan on diabetes.
Evidence indicates that low-dose tramadol is a generally safe, effective, and fast-acting antidepressant for a substantial number of individuals suffering from depression.
An overview of current theses and research surrounding the pathogenesis, presentation, and treatment of COVID-19 in children.
Cannabis use during pregnancy may harm fetal development and long-term health.
These diagnostic tests play critical role in chronic disease management, early interventions, and emergency situations.
The story of gepirone may spark new conversations for industry standards on drug development to facilitate future innovations.
Sarah Spinler, PharmD, FCCP, FAHA, FASHP, AACC, discussed management of atrial fibrillation in patients with cancer.
Health system pharmacies can enhance operational and financial performance by leveraging key performance indicators, data-driven tools, and automation, ultimately supporting the broader health system’s adaptability and growth within an evolving health care landscape.
Pharmacy school is about more than academics—it's also a time to build relationships and explore opportunities.
They should consider many factors and use clear guidance on predicting phenotypes from genotypes to intervene optimally based on specific drug-gene interactions.